MRD / Regn No. : TL/20-21/00444 Date : 23/06/2026
Patient Name : Vinay Sagare Age & Gender : 43 Yrs. / Male
Contact No. : 9004837729 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : T2DM (16/Jun/2021) | HTN (16/Jun/2021) | DYSLIPIDEMIA (16/Jun/2021) |
Subjective : T2DM,HTN,DYSLIPIDEMIA,DIABETIC DERMOPATHY,DECREASING TREND OF ALT / AST,JUNE 25 - NORMAL,BP WNL / WT STABLE / NO SYMPTOMS
Objective : MAY 26- HBA1C- 6.6/FBS-110,ACR-<30,TC- 132/TG- 108/LDL- 77/HDL- 33,AST- 22/ALT- 39,PP-144
Analysis : TYPE 2 DM X 4 YEARS
Plan : CAN DO HBA1C > 3 MTHS - IF HBA1C < 6.5% - CAN MAKE DOSE 850 MG TWICE A DAY  
S# Generic (Trade) Name Route Dosage Usage Duration
1 ALOJA 25 MG ORAL 1-0-0 AFTER BREAKFAST
 180 DAYS
2 TABLET TELMISARATAN 80 MG
TAZLOC 80 MG 		ORAL 1-0-0 ABF
 180 DAYS
3 ROZUCOR 5 MG ORAL 0-0-1 AD
 180 DAYS
4 DRISE 60,000 UNITS ORAL 1 / MTH ANYTIME OF DAY
 180 DAYS
5 DILNIP 10 MG ORAL 0-0-2 AD
 180 DAYS
6 GLUCONORM SR 1 GM ORAL 1-0-1 ABF / AD
 6 MTHS
       
Refill : 0 / Substitution:    
Education : IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL.
Next Visit : 03/Jun/2026
Tests Suggested For Next Visit : HBA1C / FBS / PPBS / LIPID PROFILE / URINE FOR MICROALB:CREAT RATIO/LFT > 6 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: